RxDoctor Payments Data

Sandra Agnes

Family · Dover, OHNPI 1710218433

Payments from drug & device makers

$249in general payments, 2019–2025

Across 15 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$65
  • AbbVie$48
  • Astellas Pharma US Inc$38
  • Lilly USA, LLC$32
  • Almatica Pharma LLC$21
  • Novo Nordisk$17
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$249100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$249 in reported general payments places this provider in the 40th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$16,391
Medicare patients
111
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin61$40,781
EliquisApixaban57$39,233
OzempicSemaglutide37$34,660
JanuviaSitagliptin Phosphate29$21,431
MounjaroTirzepatide14$16,322
TrulicityDulaglutide11$13,691
XareltoRivaroxaban14$11,338
FarxigaDapagliflozin Propanediol12$11,213
Repatha SureclickEvolocumab11$5,989
Metoprolol Succinate182$1,716
SynthroidLevothyroxine Sodium28$1,546
Levothyroxine Sodium165$1,524
Colestipol Hcl11$1,494
Atorvastatin Calcium240$1,444
Duloxetine Hcl62$1,378

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$13$40,78161 claims
PfizerEliquis$65$39,23357 claims
Novo NordiskOzempic$17$34,66037 claims
Lilly USA, LLCMounjaro, Trulicity$32$30,01325 claims
AbbVieSynthroid$48$1,54628 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 6,812 family providers in Ohio.

Other family in Dover

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →